rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2003-1-31
|
pubmed:abstractText |
The relationship between the radiation dose and the risk of the osteoradionecrosis is well known. However, the dose to the mandible is not routinely assessed in the radiotherapy for head and neck cancer. The aim of our study was to analyze the mandibular dose distribution in the patients administered curative radiotherapy for squamous cell carcinoma of the oropharynx. Moreover, the clinical results have been analyzed.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0167-8140
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
66
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
49-56
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:12559520-Adult,
pubmed-meshheading:12559520-Aged,
pubmed-meshheading:12559520-Cohort Studies,
pubmed-meshheading:12559520-Dose Fractionation,
pubmed-meshheading:12559520-Dose-Response Relationship, Radiation,
pubmed-meshheading:12559520-Female,
pubmed-meshheading:12559520-Follow-Up Studies,
pubmed-meshheading:12559520-Humans,
pubmed-meshheading:12559520-Male,
pubmed-meshheading:12559520-Mandible,
pubmed-meshheading:12559520-Maximum Tolerated Dose,
pubmed-meshheading:12559520-Middle Aged,
pubmed-meshheading:12559520-Neoplasm Staging,
pubmed-meshheading:12559520-Oropharyngeal Neoplasms,
pubmed-meshheading:12559520-Osteoradionecrosis,
pubmed-meshheading:12559520-Prospective Studies,
pubmed-meshheading:12559520-Radiation Dosage,
pubmed-meshheading:12559520-Radiotherapy, Conformal,
pubmed-meshheading:12559520-Risk Assessment,
pubmed-meshheading:12559520-Survival Analysis,
pubmed-meshheading:12559520-Treatment Outcome
|
pubmed:year |
2003
|
pubmed:articleTitle |
Analysis of mandibular dose distribution in radiotherapy for oropharyngeal cancer: dosimetric and clinical results in 18 patients.
|
pubmed:affiliation |
Division of Radiation Oncology, European Institute of Oncology, via Ripamonti 435, 20141, Milan, Italy.
|
pubmed:publicationType |
Journal Article
|